Biotest Aktiengesellschaft
FSX:BIO3.DE
27.6 (EUR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 684.6 | 516.1 | 515.6 | 484.2 | 419.1 | 400.3 | 378.1 | 553.1 | 589.6 | 582 | 500.8 | 439.967 | 422.027 | 412.482 | 440.191 | 422.956 | 0 | 0 | 0 | 217.851 | 221.889 | 257.856 |
| Cost of Revenue
| 412.7 | 391.2 | 434.9 | 354.1 | 290.3 | 265.5 | 254.6 | 349.6 | 448.3 | 357.5 | 293.2 | 255.304 | 254.266 | 247.999 | 227.87 | 203.819 | -153.84 | -139.98 | -126.106 | 114.123 | 124.395 | 142.067 |
| Gross Profit
| 271.9 | 124.9 | 80.7 | 130.1 | 128.8 | 134.8 | 123.5 | 203.5 | 141.3 | 224.5 | 207.6 | 184.663 | 167.761 | 164.483 | 212.321 | 219.137 | 153.84 | 139.98 | 126.106 | 103.728 | 97.494 | 115.789 |
| Gross Profit Ratio
| 0.397 | 0.242 | 0.157 | 0.269 | 0.307 | 0.337 | 0.327 | 0.368 | 0.24 | 0.386 | 0.415 | 0.42 | 0.398 | 0.399 | 0.482 | 0.518 | 0 | 0 | 0 | 0.476 | 0.439 | 0.449 |
| Reseach & Development Expenses
| 66.2 | 50.5 | 52.3 | 55.8 | 53.4 | 48.5 | 55.4 | 48.5 | 98.8 | 67.2 | 64.6 | 51.438 | 49.406 | 48.968 | 48.457 | 43.676 | -34.476 | -26.078 | -16.872 | 18.53 | 18.364 | 19.282 |
| General & Administrative Expenses
| 30.6 | 31.7 | 30.1 | 28.2 | 31.3 | 31.6 | 45.2 | 35.2 | 35.6 | 31.6 | 30.6 | 27.886 | 31.958 | 30.729 | 37.072 | 40.216 | 0 | 0 | 0 | 16.799 | 16.225 | 19.838 |
| Selling & Marketing Expenses
| 50.4 | 49 | 51.1 | 50.2 | 49.6 | 51.6 | 53.7 | 52.7 | 77.8 | 74.2 | 60.1 | 57.151 | 48.517 | 52.456 | 69.047 | 81.002 | -72.104 | -63.314 | -54.891 | 50.035 | -52.547 | -63.914 |
| SG&A
| 73.2 | 80.7 | 81.2 | 78.4 | 80.9 | 83.2 | 98.9 | 87.9 | 113.4 | 105.8 | 90.7 | 85.037 | 80.475 | 83.185 | 106.119 | 121.218 | -72.104 | -63.314 | -54.891 | 66.834 | -36.322 | -44.076 |
| Other Expenses
| -2.3 | 2.2 | -0.7 | -1.6 | 1.2 | 0.6 | 2.5 | 1.1 | 0.6 | -0.7 | 2 | 0.082 | -3.68 | -10.564 | -3.728 | -1.396 | 0 | 0 | 0 | -0.262 | 107.8 | 133.798 |
| Operating Expenses
| 141.7 | 133.4 | 132.8 | 132.6 | 135.5 | 132.3 | 156.8 | 137.5 | 212.8 | 171.4 | 157.3 | 134.942 | 126.201 | 121.589 | 150.848 | 163.498 | -106.58 | -89.392 | -71.763 | 85.102 | 89.842 | 109.004 |
| Operating Income
| 130.2 | -13 | -52.1 | -13.2 | -6.5 | 10.6 | -9.3 | 63.9 | -71.8 | 53.4 | 53.8 | 44.653 | 41.56 | 42.894 | 61.473 | 55.639 | 38.512 | 31.386 | 25.282 | 18.626 | 7.652 | 6.785 |
| Operating Income Ratio
| 0.19 | -0.025 | -0.101 | -0.027 | -0.016 | 0.026 | -0.025 | 0.116 | -0.122 | 0.092 | 0.107 | 0.101 | 0.098 | 0.104 | 0.14 | 0.132 | 0 | 0 | 0 | 0.085 | 0.034 | 0.026 |
| Total Other Income Expenses Net
| -23.9 | -17.8 | -10.5 | -16.8 | 5.2 | -8.5 | 7.3 | -13.3 | -2.8 | -5.3 | -2.5 | -11.551 | -12.98 | -14.441 | -12.504 | -15.107 | 0 | 0 | 0 | -12.403 | -6.205 | 10.492 |
| Income Before Tax
| 106.3 | -30.8 | -62.6 | -30 | -1.3 | -6 | -26 | 52.7 | -74.3 | 46.9 | 47.8 | 36.478 | 28.58 | 28.453 | 48.969 | 40.532 | 0 | 0 | 0 | 6.223 | 1.447 | 17.277 |
| Income Before Tax Ratio
| 0.155 | -0.06 | -0.121 | -0.062 | -0.003 | -0.015 | -0.069 | 0.095 | -0.126 | 0.081 | 0.095 | 0.083 | 0.068 | 0.069 | 0.111 | 0.096 | 0 | 0 | 0 | 0.029 | 0.007 | 0.067 |
| Income Tax Expense
| -20.7 | 0.8 | 0.7 | 1.4 | 3.4 | 6.9 | -9.6 | 18.2 | 8.2 | 27.7 | 15.8 | 13.43 | 9.85 | 8.826 | 17.07 | 12.413 | 0 | 0 | 0 | 0.369 | -3.797 | -2.52 |
| Net Income
| 127 | -31.6 | -63.3 | -31.4 | -4.7 | 181.7 | -3.5 | -45.8 | -82.5 | 19.2 | 32 | 33.408 | 48.149 | 39.485 | 28.02 | 28.119 | 0 | 0 | 0 | 5.854 | 5.244 | 19.797 |
| Net Income Ratio
| 0.186 | -0.061 | -0.123 | -0.065 | -0.011 | 0.454 | -0.009 | -0.083 | -0.14 | 0.033 | 0.064 | 0.076 | 0.114 | 0.096 | 0.064 | 0.066 | 0 | 0 | 0 | 0.027 | 0.024 | 0.077 |
| EPS
| 3.21 | -0.8 | -1.6 | -0.79 | -0.12 | 4.59 | -0.088 | -1.16 | -2.08 | 0.48 | 0.85 | 0.94 | 1.31 | 1.04 | 0.72 | 0.72 | 0 | 0 | 0 | 0.19 | -0.26 | 0.85 |
| EPS Diluted
| 3.21 | -0.8 | -1.6 | -0.79 | -0.12 | 4.59 | -0.088 | -1.16 | -2.08 | 0.48 | 0.85 | 0.94 | 1.31 | 1.04 | 0.72 | 0.72 | 0 | 0 | 0 | 0.19 | -0.26 | 0.85 |
| EBITDA
| 166.1 | 22.8 | -20.7 | 16.4 | 25.2 | 26.6 | -18.8 | 90.5 | 28.8 | 90.3 | 82 | 78.349 | 93.979 | 81.799 | 94.619 | 85.805 | 276.787 | 244.865 | 212.167 | 31.494 | 18.667 | 26.355 |
| EBITDA Ratio
| 0.243 | 0.044 | -0.04 | 0.034 | 0.06 | 0.066 | -0.05 | 0.164 | 0.049 | 0.155 | 0.164 | 0.178 | 0.223 | 0.198 | 0.215 | 0.203 | 0 | 0 | 0 | 0.145 | 0.084 | 0.102 |